PTPN2 and neoplasm: Although it may be possible to target PTPN2 systemically with drugs to enhance T‐cell and CAR T‐cell responses and potentially achieve synergistic effects through the targeting of PTPN2 in both tumour cells and T cells/CAR T cells, there are several important considerations.